Parathyroid Diseases Withdrawn Phase 3 Trials for Lidocaine (DB00281)

Also known as: Parathyroid Disease

IndicationStatusPhase
DBCOND0036113 (Parathyroid Diseases)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00528502Lidocaine Supplement for Minimal Invasive Parathyroid SurgeryTreatment